PD-Rx Pharmaceuticals, Inc. recalls
Every recall we track for PD-Rx Pharmaceuticals, Inc. — 25 in all, from 2015–2024 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls per year, by danger level
Recalls from PD-Rx Pharmaceuticals, Inc. peaked in 2020 (7); 21 since 2017. 5% rated “stop using now”.
All FDA recall records for PD-Rx Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 1 | 1 | 2 |
| 2018 | 0 | 0 | 1 | 1 | 2 |
| 2019 | 0 | 0 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 5 | 0 | 7 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 3 | 3 |
| 2023 | 0 | 0 | 1 | 4 | 5 |
| 2024 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
PD-Rx Pharmaceuticals, Inc. recalls before 2017
Recalls on record by year.
Most common reasons for PD-Rx Pharmaceuticals, Inc. recalls
What to do if you have a recalled PD-Rx Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All PD-Rx Pharmaceuticals, Inc. recalls
17 shown- UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127,
PD-Rx Pharmaceuticals recalls DULoxetine 30mg 90-count bottles due to potential nitrosamine impurity. This may pose health risks. Consumers should contact the company for details.
PD-Rx PharmaceuticalsDec 4, 2024 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated
PD-Rx Pharmaceuticals recalls 4mg Glimepiride USP bottles due to CGMP deviations. Affected lots have specific expiration dates and NDC numbers. Consumers should contact the manufacturer for details.
PD-Rx PharmaceuticalsApr 6, 2023 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals,
PD-Rx Pharmaceuticals recalls 50mg Losartan Potassium Tablets due to AZIDO impurity levels exceeding safety limits. Affected lots manufactured in India with specific expiration dates.
PD-Rx PharmaceuticalsJun 6, 2022 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 tablets NDC:
PD-Rx Pharmaceuticals recalls metformin HCl ER 750mg tablets with N-Nitrosodimethylamine (NDMA) impurity above safe levels. Affected lots expire through March 2022. Consumers should stop using and contact for return.
PD-RxOct 6, 2020 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4)
PD-Rx Pharmaceuticals recalls Nature-Throid 1 GR (65 mg) tablets due to manufacturing deviations causing potential sub-potent levels. Affected products were repackaged under the same conditions as sub-potent products. No specific remedy is listed in the recall notice.
PD-Rx PharmaceuticalsSep 17, 2020 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls metFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90 tablets (NDC
PD-Rx Pharmaceuticals recalls metformin ER 500mg tablets with N-Nitrosodimethylamine (NDMA) impurity above safe levels. Consumers should stop using affected lots.
PD-RxJun 5, 2020 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls metFORMIN HCL ER USP 500 mg, a) 30 tablets (NDC: 43063-428-30); b) 60 tablets (NDC: 43063-428-60); c) 90 tablets (NDC:
PD-Rx Pharmaceuticals recalls metformin ER 500mg tablets with N-Nitrosodimethylamine (NDMA) impurity above safe levels. Consumers should stop using affected lots.
PD-RxJun 5, 2020 - Use cautionDrug
PD-Rx Pharmaceuticals, Inc. recalls Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC
PD-Rx recalls Doxycycline Hyclate 100 mg tablets due to failed dissolution specifications. Check lot numbers and expiration dates for affected batches.
PD-Rx PharmaceuticalsMay 15, 2020 - Stop using nowDrug
PD-Rx Pharmaceuticals, Inc. recalls ranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottles (NDC
PD-Rx Pharmaceuticals recalls 150mg ranitidine hydrochloride tablets with potential nitrosodimethylamine (NDMA) levels above safety limits. Consumers should stop using affected bottles.
PD-Rx PharmaceuticalsJan 10, 2020 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets
PD-Rx Pharmaceuticals recalls 50mg Losartan Potassium tablets due to trace NMBA contamination. Consumers should contact the company for details on affected lots and disposal instructions.
PD-Rx PharmaceuticalsMar 8, 2019 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count bottles, NDC
PD-Rx Pharmaceuticals recalls 100mg Doxycycline Hyclate tablets with failed dissolution tests. These may not work as intended. Check NDC codes and expiration dates for affected lots.
PD-Rx PharmaceuticalsAug 7, 2018 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC
PD-Rx Pharmaceuticals recalls 200mg ibuprofen tablets with NDC codes 55289-673-24, 55289-673-30, 55289-673-50, and 55289-673-60 due to CGMP deviations. Consumers should check their product labels.
PD-Rx PharmaceuticalsJan 25, 2018 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls Phentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC 55289-791-14), c) 21-count
PD-Rx Pharmaceuticals recalls 15mg Phentermine Capsules due to impurities detected in stability testing. Affected bottles have specific NDC numbers and expiration dates. Consumers should contact the manufacturer for details.
PD-Rx PharmaceuticalsAug 11, 2017 - Lower riskDrug
PD-Rx Pharmaceuticals, Inc. recalls Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC
PD-Rx Pharmaceuticals recalls Famotidine 20mg tablets due to weight specification failure. Affected lots may have incorrect tablet weight.
PD-Rx PharmaceuticalsJul 28, 2017 - UnratedDrug
PD-Rx Pharmaceuticals, Inc. recalls Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 7-count (NDC 55289-791-07), b) 14-count (NDC
PD-Rx recalls 15 mg Phentermine capsules due to failed impurity specifications. Check lot numbers and expiration dates for affected bottles.
PD-Rx PharmaceuticalsJul 21, 2015 - Use cautionDrug
PD-Rx Pharmaceuticals, Inc. recalls Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc.,
PD-Rx Pharmaceuticals recalls 9 bottles of 0.1 mg Clonidine Hydrochloride Tablets due to current Good Manufacturing Practice deviations.
PD-Rx PharmaceuticalsJul 10, 2015 - Use cautionDrug
PD-Rx Pharmaceuticals, Inc. recalls Azithromycin Tablets, USP, 250 mg, Rx Only, packaged in a) 2 count and b) 4 count bottles, Packaged by: PD-RX
PD-Rx recalls Azithromycin 250mg tablets due to cGMP deviations. Check lot numbers and expiration dates for affected bottles distributed nationwide.
PD-Rx PharmaceuticalsApr 29, 2015
PD-Rx Pharmaceuticals, Inc. recall questions
How many recalls has PD-Rx Pharmaceuticals, Inc. had?
25 recalls from PD-Rx Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2015–2024.
What is the most recent PD-Rx Pharmaceuticals, Inc. recall?
PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127,, dated Dec 4, 2024. Every PD-Rx Pharmaceuticals, Inc. recall is listed on this page, newest first.
Why are PD-Rx Pharmaceuticals, Inc. products recalled?
The most common reasons on record: CGMP deviations. (6); CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits (3).
What should I do if I have a recalled PD-Rx Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new PD-Rx Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.